Michael McTague: The pharmaceutical giants leading the market-cap parade in 2025
COMPANY PROFILE
Lilly(Eli) & Co
Chart
Overview
Financials
Related Articles
The health-care stocks to watch as treatment innovations shake up patient care
Michael McTague: In 2025, the pharmaceutical industry is ripe for M&A
Roche shifts toward obesity medication
Impact investors: Here are your best election-year portfolio strategies
Morningstar launches LGBTQ+ index of top 100 inclusive companies
Obesity, oncology and old age: How 2023 pharmaceutical M&A is reshaping the health-care industry
3 Growth Stock Picks That Still Have Room to Grow
